Immune Checkpoint Therapy in Melanoma
- PMID: 27111901
- DOI: 10.1097/PPO.0000000000000183
Immune Checkpoint Therapy in Melanoma
Abstract
Checkpoint-blocking antibodies have transformed cancer therapy, and the treatment of patients with metastatic melanoma has led the revolution. Herein, we review the current clinical data supporting the use of checkpoint-blocking antibodies in the treatment of melanoma and highlight outstanding clinical questions and unmet clinical needs.
Similar articles
-
Immune Checkpoint Therapies in Prostate Cancer.Cancer J. 2016 Mar-Apr;22(2):117-20. doi: 10.1097/PPO.0000000000000176. Cancer J. 2016. PMID: 27111907 Free PMC article. Review.
-
Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies.Cancer J. 2016 Mar-Apr;22(2):101-7. doi: 10.1097/PPO.0000000000000179. Cancer J. 2016. PMID: 27111905 Review.
-
The State of Immune Checkpoint Inhibition in Urothelial Carcinoma: Current Evidence and Future Areas of Exploration.Cancer J. 2016 Mar-Apr;22(2):96-100. doi: 10.1097/PPO.0000000000000175. Cancer J. 2016. PMID: 27111904 Review.
-
Immune Checkpoint Therapy in Head and Neck Cancers.Cancer J. 2016 Mar-Apr;22(2):108-16. doi: 10.1097/PPO.0000000000000180. Cancer J. 2016. PMID: 27111906 Review.
-
Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.Clin Adv Hematol Oncol. 2016 Nov;14(11):922-933. Clin Adv Hematol Oncol. 2016. PMID: 27930644 Review.
Cited by
-
A bibliometric and visualized research on global trends of immune checkpoint inhibitors related complications in melanoma, 2011-2021.Front Endocrinol (Lausanne). 2023 Apr 20;14:1164692. doi: 10.3389/fendo.2023.1164692. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37152956 Free PMC article.
-
Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis.Curr Oncol. 2022 Feb 4;29(2):881-891. doi: 10.3390/curroncol29020075. Curr Oncol. 2022. PMID: 35200574 Free PMC article. Review.
-
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models.Oncoimmunology. 2018 Mar 26;7(7):e1445457. doi: 10.1080/2162402X.2018.1445457. eCollection 2018. Oncoimmunology. 2018. PMID: 29900058 Free PMC article.
-
Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.Front Oncol. 2018 May 24;8:173. doi: 10.3389/fonc.2018.00173. eCollection 2018. Front Oncol. 2018. PMID: 29881716 Free PMC article. Review.
-
The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma Progression.Immunity. 2017 Aug 15;47(2):284-297.e5. doi: 10.1016/j.immuni.2017.07.020. Immunity. 2017. PMID: 28813659 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical